Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

Rock Creek Pharmaceuticals Announces Listing Extension on NASDAQ (company announcement)
Dec 11, 2014

Excerpt:
"SARASOTA, Fla., Dec. 11, 2014 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today that it received notification from the Nasdaq Stock Market, Inc. granting a six-month extension of its Nasdaq listing. The Company has until April 27, 2015 to maintain a closing bid price of at least $1.00 for a minimum of 10 consecutive days to maintain compliance with Nasdaq listing requirements. The extension is also subject to the condition that the Company



provide certain written updates to Nasdaq during the extension period and that Rock Creek file, on or before February 23, 2015, a preliminary proxy statement for a shareholder meeting for a reverse stock split proposal.

Rock Creek Pharmaceuticals
In addition, the Company has applied to transfer its listing from The Nasdaq Global Market to The Nasdaq Capital Market, which should go into effect on December 15, 2014. The Company believes that The Nasdaq Capital Market is better suited to smaller companies, such as Rock Creek Pharmaceuticals."

Announcement at:
http://investors.rockcreekpharmaceuticals.com/2014-12-11-Rock-Creek-Pharmaceuticals-Announces-Listing-Extension-on-NASDAQ